Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion type Assertion NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_head.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion wasGeneratedBy ECO_0000203 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion wasDerivedFrom befree-20140225 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion SIO_000772 21607772 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion evidence source_evidence_literature NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion description "[In survival after tumor recurrence, the EGFR group had a better median survival time (46.7 months) after recurrence than the KRAS group (26.0 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.